03.01.06
Kaneka Completes Expansion of CoQ10 Production Facilities
Kaneka Corp., Osaka, Japan, has completed the planned expansion of its CoQ10 facilities in Takasago, Japan, and has begun commercial shipment of KanekaQ10 to customers after meeting the required pharmaceutical validations and safety confirmation of its production facility. This new expansion brings Kaneka’s annual CoQ10 production capacity in Japan from 150 metric tons to 180 metric tons, an expansion needed in order to meet steadily increasing CoQ10 demand worldwide.
Meanwhile, in the U.S., Kaneka Nutrients LP, Pasadena, TX, a fully owned subsidiary of Kaneka Corp., is building a new CoQ10 plant with an annual production capacity of 100 metric tons. This Phase I construction is expected to be completed by the summer of 2006, thus enabling Kaneka to better meet the strong increase in CoQ10 consumption both in the U.S. and other worldwide markets.
Kaneka Corp., Osaka, Japan, has completed the planned expansion of its CoQ10 facilities in Takasago, Japan, and has begun commercial shipment of KanekaQ10 to customers after meeting the required pharmaceutical validations and safety confirmation of its production facility. This new expansion brings Kaneka’s annual CoQ10 production capacity in Japan from 150 metric tons to 180 metric tons, an expansion needed in order to meet steadily increasing CoQ10 demand worldwide.
Meanwhile, in the U.S., Kaneka Nutrients LP, Pasadena, TX, a fully owned subsidiary of Kaneka Corp., is building a new CoQ10 plant with an annual production capacity of 100 metric tons. This Phase I construction is expected to be completed by the summer of 2006, thus enabling Kaneka to better meet the strong increase in CoQ10 consumption both in the U.S. and other worldwide markets.